This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

FutureFuel Releases Third Quarter 2013 Results

  Financial Overview and Key Operating Metrics

Financial and operating metrics, which include non-GAAP financial measures, include:

FutureFuel Corp.

Certain Financial and Operating Metrics

(Dollars in thousands, except per share amounts)

(Unaudited)

         
  Three Months Ended Three Months Ended     
  September 30, 2013 September 30, 2012 Dollar Change % Change
Revenues  $ 121,119  $ 88,276  $ 32,843 37.2%
Income from operations  $ 23,515  $ 19,181  $ 4,334 22.6%
Net income  $ 15,297  $ 12,549  $ 2,748 21.9%
Earnings per common share – basic  $ 0.35  $ 0.30  $ 0.05 16.7%
Earnings per common share – diluted  $ 0.35  $ 0.30  $ 0.05 16.7%
Capital expenditures (net of reimbursements)  $ 7,570  $ 2,656  $ 4,914 185.0%
Adjusted EBITDA  $ 28,177  $ 23,991  $ 4,186 17.4%
         
         
  Nine Months Ended Nine Months Ended    
  September 30, 2013 September 30, 2012 Dollar Change % Change
Revenues  $ 319,347  $ 277,240  $ 42,107 15.2%
Income from operations  $ 67,440  $ 41,336  $ 26,104 63.2%
Net income  $ 47,503  $ 28,135  $ 19,368 68.8%
Earnings per common share - basic  $ 1.10  $ 0.68  $ 0.42 61.8%
Earnings per common share – diluted  $ 1.10  $ 0.68  $ 0.42 61.8%
Capital expenditures (net of customer reimbursements and grants)  $ 11,179  $ 6,435  $ 4,744 73.7%
Adjusted EBITDA  $ 71,251  $ 46,515  $ 24,736 53.2%

Third Quarter Financial and Business Summary

Revenues for the three months ended September 30, 2013 were $121,119,000 as compared to revenues for the three months ended September 30, 2012 of $88,276,000, an increase of 37%. Revenues from biofuels were up 61% and accounted for 64% of total revenues in the third quarter of 2013 as compared to 54% in the third quarter of 2012. Revenues from chemicals increased 8% and accounted for 36% of total revenues in the third quarter of 2013 as compared to 46% in the third quarter of 2012. Within the chemicals segment, revenues for the three months ended September 30, 2013 changed as follows compared to the three months ended September 30, 2012: (i) revenues from other custom chemicals increased 47%; (ii) revenues from the industrial intermediate utilized in the antimicrobial industry increased 39%; (iii) revenues from other performance chemicals increased 23% (iv) revenues from CPOs increased 27%; (v) revenues from DIPB decreased 25%; and (vi) revenues from the proprietary herbicide and intermediates decreased 25%.  Revenues from the bleach activator were unchanged.

2 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs